ECO Animal Health Group plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EAH.L research report →
Companywww.ecoanimalhealthgroupplc.com
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.
- CEO
- David Charles Hallas
- IPO
- 1995
- Employees
- 227
- HQ
- New Malden, GB
Price Chart
Valuation
- Market Cap
- $65.12M
- P/E
- 21.56
- P/S
- 0.76
- P/B
- 0.77
- EV/EBITDA
- 5.37
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 49.06%
- Op Margin
- 7.71%
- Net Margin
- 3.52%
- ROE
- 3.55%
- ROIC
- 5.29%
Growth & Income
- Revenue
- $79.60M · -10.99%
- Net Income
- $1.69M · 60.88%
- EPS
- $0.02 · 60.65%
- Op Income
- $4.30M
- FCF YoY
- 10.14%
Performance & Tape
- 52W High
- $116.90
- 52W Low
- $55.55
- 50D MA
- $95.98
- 200D MA
- $94.58
- Beta
- 0.01
- Avg Volume
- 73.94K
Get TickerSpark's AI analysis on EAH.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our EAH.L Coverage
We haven't published any research on EAH.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EAH.L Report →